Walk into a modern cannabis-adjacent shop and cannabis is no longer the only plant on the wall. Kanna, blue lotus, amanita, kava, damiana, mugwort, and a rotating cast of adaptogenic mushrooms now occupy meaningful shelf space. Some of this is genuine botanical tradition finding a new audience. Some of it is marketing dressed in Latin binomials. Telling the difference is worth doing.

Why the Category Expanded

Three forces converged. Cannabis retail normalized the idea of buying a plant product for a subjective effect. The functional mushroom boom trained consumers to accept botanical supplements with wellness framing. And a substantial cohort of consumers started looking for options that were not THC, either because of drug testing, because they had a bad relationship with cannabis, or because they wanted something in the rotation that did not carry the same intensity.

Retailers noticed that these customers were already in the store.

The Ones With Actual Tradition Behind Them

Kanna (Sceletium tortuosum). A South African succulent with centuries of documented use by Khoisan peoples. Modern interest centers on mesembrine alkaloids and their serotonergic activity. It is typically described as mood-lifting and mildly euphoric rather than sedating. Notably, it has real pharmacological interaction potential. Kanna should not be combined with SSRIs, MAOIs, or other serotonergic medications, and that warning is frequently absent from packaging.

Blue lotus (Nymphaea caerulea). Egyptian iconography is full of it, and the traditional preparation was a wine infusion rather than smoking. Contains apomorphine and nuciferine. Effects are commonly described as gently sedating and dreamlike. The evidence base is thin but the tradition is genuine.

Kava (Piper methysticum). The best-documented of the group. Pacific Islander ceremonial use going back millennia, and a reasonable body of clinical literature on anxiolytic effects. The important caveat is hepatotoxicity risk, particularly with acetone or ethanol extracts and particularly in combination with alcohol. Traditional water-extracted noble kava has a much better safety record than the extracts that caused European regulatory action in the 2000s.

Damiana (Turnera diffusa). Long history in Mexican and Central American herbal practice. Mild, pleasant, and largely uncontroversial. Frequently blended into smoking mixtures as a base.

The Ones That Warrant More Caution

Amanita muscaria has moved into mainstream retail quickly, and it deserves more scrutiny than it usually gets. It is not psilocybin. Its active compounds, muscimol and ibotenic acid, work on a completely different receptor system, and ibotenic acid is the one responsible for the nausea and dysphoria in poorly prepared products. Preparation and decarboxylation quality vary enormously between brands, dosing conventions are not standardized, and the effect profile is genuinely unpredictable at higher amounts. Approach it as a distinct substance rather than a legal mushroom substitute.

What Separates a Real Product From a Repackaged One

The botanical category has a documentation problem that cannabis largely solved. Ask for the same things you would demand of a cannabis product:

Species identification, not just a common name. "Blue lotus" on a label with no binomial could be several things. Reputable suppliers name the species.

Extract ratio and standardization. A 10:1 extract and raw dried plant material are not interchangeable, and dosing accordingly matters. If a label says "extract" with no ratio, you cannot dose it.

Contaminant testing. Imported botanical material carries real heavy metal and pesticide risk. Third-party lab results should exist.

Interaction warnings. Any vendor selling kanna without an SSRI warning is not paying attention to what they are selling.

Retailers that carry these alongside hemp products tend to apply cannabis-grade documentation standards to them, which is an improvement over the supplement aisle norm. Browsing a curated botanical extracts catalog is a useful way to see which brands publish species, ratios, and lab work, and which ones sell an evocative name and a nice label.

A Reasonable Approach

Try one thing at a time. Botanical stacking is popular and makes it impossible to know what did what, and in the case of serotonergic compounds it can be genuinely risky. Start at the low end of any stated range. Keep notes. Give a substance at least three separate sessions before deciding it works or does not. Set and setting affect these as much as they affect cannabis.

And talk to a pharmacist if you take prescription medication. Most of these compounds have not been studied for interactions, which is not the same as being free of them.

Informational only; not medical advice. These products are not evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Adults 21+.

Photo: Peripitus via Wikimedia Commons, CC BY-SA 3.0